Immunovant IMVT Q1 2026 Earnings EPS Miss Driven by Higher RD Investment Stock Holds Steady STAG Q1 2026 Earnings Significant EPS Beat Driven by Operational Efficiency Ball Corporation Q1 2026 Earnings EPS Beats Estimates by 885 on Strong Operational Performance CV Q1 2026 Earnings EPS Misses Estimates as Losses Widen Amid No Revenue Disclosure Vor Biopharma Q1 2026 Earnings Wide EPS Miss Sends Stock Down 47 Amid Ongoing Clinical Development AKBA Q1 2026 Earnings EPS Misses Estimates as Stock Holds Steady